arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 12/2023 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    Tirzepatide (MOUNJARO) for type 2 diabetes

    THERAPY FROM A CRITICAL VIEWPOINT

    ORBITA-2 trial – resurrection of stent insertion in chronic coronary artery disease?

    REVIEW

    Biologics and small molecules for ulcerative colitis

    BEWARE MISINFORMATION

    Misleading warning about COVID-19 mRNA vaccines

    Study on HOMVIOTENSIN … “a well-protected company asset”?

    IN BRIEF

    Example topical diclofenac – reducing the environmental impact of drugs – freely available article
    free

    SIDE EFFECTS

    Black hairy tongue – unaesthetic but benign

    New contraindications for pseudoephedrine-containing cold remedies

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles

    Wir schätzen Ihr Feedback

    Nehmen Sie an unserer Umfrage teil!